Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT01_J20_apoEKI_Bumex_snRNA-seq]

ABSTRACT: Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT01_J20_apoEKI_Bumex_snRNA-seq]

PROVIDER: PRJNA757731 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15610188_1.fastq.gz	Fastqsanger.gz
	SRR15610188_2.fastq.gz	Fastqsanger.gz
	SRR15610189_1.fastq.gz	Fastqsanger.gz
	SRR15610189_2.fastq.gz	Fastqsanger.gz
	SRR15610190_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease

Project description:Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease

| PRJNA757725 | ENA

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT02_apoE4KI_Bumex_snRNA-seq]

Project description:Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT02_apoE4KI_Bumex_snRNA-seq]

| PRJNA757728 | ENA

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT2123B_iPS_Bumex_RNA-seq]

Project description:Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT2123B_iPS_Bumex_RNA-seq]

| PRJNA757727 | ENA

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT01_J20_apoEKI_Bumex_snRNA-seq]

Project description:The evident genetic, pathological, and clinical heterogeneity of Alzheimer’s disease (AD) poses challenges for traditional drug development. We conducted a computational drug repurposing screen for drugs to treat apolipoprotein (apo) E4-related AD. We first established apoE-genotype-dependent transcriptomic signatures of AD by analyzing publicly-available human brain database. We then queried these signatures against the Connectivity Map database containing transcriptomic perturbations of >1300 drugs to identify those that best reverse apoE-genotype-specific AD signatures. Bumetanide was identified as a top drug for apoE4 AD. Bumetanide treatment of apoE4 mice without or with Ab accumulation rescued electrophysiological, pathological, or cognitive deficits. Single-nucleus RNA-sequencing revealed transcriptomic reversal of AD signatures in specific cell types in these mice, a finding confirmed in apoE4-iPSC-derived neurons. In humans, bumetanide exposure was associated with a significantly lower AD prevalence in individuals over the age of 65 in two EHR databases, suggesting effectiveness of bumetanide in preventing AD.

2021-10-03 | GSE182764 | GEO

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT02_apoE4KI_Bumex_snRNA-seq]

2021-10-03 | GSE182762 | GEO

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease [AT2123B_iPS_Bumex_RNA-seq]

2021-10-03 | GSE182761 | GEO

Computational Repurposing of Bumetanide for Preventing or Treating Alzheimer’s Disease

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-10-03 | GSE182765 | GEO

Beta,Beta-Dimethylacryloyl shikonin, mechanism of preventing and treating zebrafish soybean meal enteritis

Project description:The aim of this study is to explore through transcriptomics, β, β Dimethylacryloyl shikonin, mechanism for preventing and treating in zebrafish.

2024-08-15 | GSE273916 | GEO

Beta,Beta-Dimethylacryloyl shikonin, mechanism of preventing and treating zebrafish soybean meal enteritis

Project description:Beta,Beta-Dimethylacryloyl shikonin, mechanism of preventing and treating zebrafish soybean meal enteritis

| PRJNA1144090 | ENA

Computational Genomics of Preeclampsia

Project description:Computational Genomics of Preeclampsia

| PRJNA809816 | ENA